Kanamycine-OVA

Kanamycin-OVA is a conjugate of Kanamycin and Ovalbumin (OVA). By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells[1].

12352100

Biochemical Assay Reagents

Others

Inflammation/Immunology

[Kanamycin-OVA]

[1]YANAGISAWA K, et al. Studies on kanamycin, a new antibiotic against tubercle bacilli. I. Effect on virulent tubercle bacilli in vitro and in mice. J Antibiot (Tokyo) . 1957 Nov;10 (6) :233-5.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-NP0250A/

Biochemical Assay Reagents

No Development Reported